Abstract:Advanced MaterialsVolume 23, Issue 12 p. H84-H89 Communication “Advanced Healthcare Materials” RGD-Modified PEG-PAMAM-DOX Conjugate: In Vitro and In Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells Saijie Zhu, Saijie Zhu Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLili Qian, Lili Qian Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorMinghuang Hong, Minghuang Hong Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLihong Zhang, Lihong Zhang Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYuanying Pei, Yuanying Pei Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYanyan Jiang, Corresponding Author Yanyan Jiang [email protected] Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaDepartment of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. China.Search for more papers by this author Saijie Zhu, Saijie Zhu Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLili Qian, Lili Qian Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorMinghuang Hong, Minghuang Hong Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLihong Zhang, Lihong Zhang Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYuanying Pei, Yuanying Pei Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYanyan Jiang, Corresponding Author Yanyan Jiang [email protected] Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaDepartment of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. China.Search for more papers by this author First published: 01 March 2011 https://doi.org/10.1002/adma.201003944Citations: 109Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract A novel multifunctional drug–polymer conjugate is prepared. RGD peptide is used to actively target the drug delivery system to tumor neovascular endothelial cells and tumor cells, while the PEG-PAMAM polymeric carrier permits passive targeting to the tumor site by the enhanced permeability and retention (EPR) effect. Controlled release of the anticancer drug doxorubicin is also achieved via acid-sensitive cis-aconityl linkage. Supporting Information Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description adma_201003944_sm_suppl.pdf851 KB suppl Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. References 1 W. Cai, G. Niu, X. Chen, Curr. Pharm. Des. 2008, 14, 2943. 10.2174/138161208786404308 CASPubMedWeb of Science®Google Scholar 2 K. Temming, R. M. Schiffelers, G. Molema, R. J. Kok, Drug Resist. Updates 2005, 8, 381. 10.1016/j.drup.2005.10.002 CASPubMedWeb of Science®Google Scholar 3 M. P. Borgman, O. Aras, S. Geyser-Stoops, E. A. Sausville, H. Ghandehari, Mol. Pharmaceutics 2009, 6, 1836. 10.1021/mp900134c CASPubMedWeb of Science®Google Scholar 4 M. Oba, K. Aoyagi, K. Miyata, Y. Matsumoto, K. Itaka, N. Nishiyama, Y. Yamasaki, H. Koyama, K. Kataoka, Mol. Pharmaceutics 2008, 5, 1080. 10.1021/mp800070s CASPubMedWeb of Science®Google Scholar 5 Z. Liu, S. Liu, G. Niu, F. Wang, S. Liu, X. Chen, Mol. Imaging 2010, 9, 21. CASPubMedWeb of Science®Google Scholar 6 S. Zhu, M. Hong, L. Zhang, G. Tang, Y. Jiang, Y. Pei, Pharm. Res. 2010, 27, 161. 10.1007/s11095-009-9992-1 CASPubMedWeb of Science®Google Scholar 7 S. Zhu, M. Hong, G. Tang, L. Qian, J. Lin, Y. Jiang, Y. Pei, Biomaterials 2010, 31, 1360. 10.1016/j.biomaterials.2009.10.044 CASPubMedWeb of Science®Google Scholar 8 D. B. Leeper, K. Engin, A. J. Thistlethwaite, H. D. Hitchon, J. D. Dover, D. J. Li, L. Tupchong, Int. J. Radiat. Oncol. Biol. Phys. 1994, 28, 935. 10.1016/0360-3016(94)90114-7 CASPubMedWeb of Science®Google Scholar 9 A. S. E. Ojugo, P. M. J. McSheehy, D. J. O. McIntyre, C. McCoy, M. Stubbs, M. O. Leach, I. R. Judson, J. R. Griffiths, NMR Biomed. 1999, 12, 495. 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K CASPubMedWeb of Science®Google Scholar 10 R. van Sluis, Z. M. Bhujwalla, N. Raghunand, P. Ballesteros, J. Alvarez, S. Cerdán, J. P. Galons, R. J. Gillies, Magn. Reson. Med. 1999, 41, 743. 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar 11 J. Liu, J. I. Shapiro, Biol. Res. Nurs. 2003 , 5, 117. 10.1177/1099800403256860 PubMedGoogle Scholar 12 J. Z. Du, T. M. Sun, W. J. Song, J. Wu, J. Wang, Angew. Chem. Int. Ed. 2010, 49, 3621. 10.1002/anie.200907210 CASPubMedWeb of Science®Google Scholar 13 R. Kluger, C. H. Lam, J. Am. Chem. Soc. 1978, 100, 2191. 10.1021/ja00475a033 CASWeb of Science®Google Scholar 14 D. Q. McNerny, J. F. Kukowska-Latallo, D. G. Mullen, J. M. Wallace, A. M. Desai, R. Shukla, B. Huang, M. M. Banaszak Holl, J. R. Baker, Bioconjugate Chem. 2009, 20, 1853. 10.1021/bc900217h CASPubMedWeb of Science®Google Scholar 15 W. Lu, Q. Sun, J. Wan, Z. She, X. G. Jiang, Cancer Res. 2006, 66, 11878. 10.1158/0008-5472.CAN-06-2354 CASPubMedWeb of Science®Google Scholar 16 N. Nasongkla, X. Shuai, H. Ai, B. D. Weinberg, J. Pink, D. A. Boothman, J. Gao, Angew. Chem. Int. Ed. 2004, 43, 6323. 10.1002/anie.200460800 CASPubMedWeb of Science®Google Scholar 17 R. M. Schiffelers, G. A. Koning, T. L. ten Hagen, M. H. Fens, A. J. Schraa, A. P. Janssen, P. J. Kok, G. Molema, G. Storm, J. Controlled Release 2003, 91, 115. 10.1016/S0168-3659(03)00240-2 CASPubMedWeb of Science®Google Scholar 18 A. K. Singh, B. S. Kasinath, E. J. Lewis. Biochim. Biophys. Acta 1992, 1120, 337. 10.1016/0167-4838(92)90257-E CASPubMedWeb of Science®Google Scholar 19 O. P. Perumal, R. Inapagolla, S. Kannan, R. M. Kannan, Biomaterials 2008, 29, 3469. 10.1016/j.biomaterials.2008.04.038 CASPubMedWeb of Science®Google Scholar 20 M. Hong, S. Zhu, Y. Jiang, G. Tang, Y. Pei, J. Controlled Release 2009, 133, 96. 10.1016/j.jconrel.2008.09.005 CASPubMedWeb of Science®Google Scholar 21 N. Kamaly, T. Kalber, M. Thanou, J. D. Bell, A. D. Miller, Bioconjugate Chem. 2009, 20, 648. 10.1021/bc8002259 CASPubMedWeb of Science®Google Scholar 22 S. Samanta, R. Sistla, A. Chaudhuri, Biomaterials 2010, 31, 1787. 10.1016/j.biomaterials.2009.10.027 CASPubMedWeb of Science®Google Scholar 23 D. H. Yu, Q. Lu, J. Xie, C. Fang, H. Z. Chen, Biomaterials 2010, 31, 2278. 10.1016/j.biomaterials.2009.11.047 CASPubMedWeb of Science®Google Scholar 24 Q. Cao, Z. Li, K Chen, Z. Wu, L. He, N. Neamati, X. Chen, Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 1489. 10.1007/s00259-008-0744-y CASPubMedWeb of Science®Google Scholar 25 A. Nanda, B. St Croix, Curr. Opin. Oncol. 2004, 16, 44. 10.1097/00001622-200401000-00009 CASPubMedWeb of Science®Google Scholar 26 R. Tomlinson, J. Heller, S. Brocchini, R. Duncan, Bioconjugate Chem. 2003, 14, 1096. 10.1021/bc030028a CASPubMedWeb of Science®Google Scholar 27 X. B. Xiong, Y. Huang, W. L. Lu, X. Zhang, H. Zhang, T. Nagai, Q. Zhang, J. Controlled Release 2005, 107, 262. 10.1016/j.jconrel.2005.03.030 CASPubMedWeb of Science®Google Scholar Citing Literature Volume23, Issue12March 25, 2011Pages H84-H89 ReferencesRelatedInformation

Abstract:NanomedicineVol. 9, No. 8 EditorialRecent progress in multidrug delivery to cancer cells by liposomesRan Mo, Tianyue Jiang & Zhen GuRan MoJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USAMolecular Pharmaceutics Division, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USAState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China, Tianyue JiangJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USAMolecular Pharmaceutics Division, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USAState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China & Zhen GuAuthor for correspondence: E-mail Address: zgu@email.unc.eduJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USAMolecular Pharmaceutics Division, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USAPublished Online:14 Aug 2014https://doi.org/10.2217/nnm.14.62AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: chemotherapyco-deliverycombination cancer therapydrug deliverygene therapyliposomeprotein therapyReferences1 Bangham AD, Standish MM, Watkins JC et al. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13(1), 238–252 (1965).Crossref, Medline, CAS, Google Scholar2 Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine 8(9), 1509–1528 (2013).Link, CAS, Google Scholar3 Wang B, Galliford CV, Low PS. Guiding principles in the design of ligand-targeted nanomedicines. Nanomedicine 9(2), 313–330 (2014).Link, CAS, Google Scholar4 Mayer LD, Harasym TO, Tardi PG et al. Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Mol. Cancer Ther. 5(7), 1854–1863 (2006).Crossref, Medline, CAS, Google Scholar5 Batist G, Gelmon KA, Chi KN et al. Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clin. Cancer Res. 15(2), 692–700 (2009).Crossref, Medline, CAS, Google Scholar6 Feldman EJ, Lancet JE, Kolitz JE et al. First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia. J. Clin. Oncol. 29(8), 979–985 (2011).Crossref, Medline, CAS, Google Scholar7 Feldman EJ, Kolitz JE, Trang JM et al. Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia. Leuk. Res. 36(10), 1283–1289 (2012).Crossref, Medline, CAS, Google Scholar8 Wong MY, Chiu GN. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine 7(6), 834–840 (2011).Crossref, Medline, CAS, Google Scholar9 Zucker D, Andriyanov AV, Steiner A et al. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy. J. Controlled Release 160(2), 281–289 (2012).Crossref, Medline, CAS, Google Scholar10 Ong JC, Sun F, Chan E. Development of stealth liposome coencapsulating doxorubicin and fluoxetine. J. Liposome Res. 21(4), 261–271 (2011).Crossref, Medline, CAS, Google Scholar11 Sawant RR, Vaze OS, Rockwell K, Torchilin VP..Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur. J. Pharm. Biopharm. 75(3), 321–326 (2010).Crossref, Medline, CAS, Google Scholar12 Maitani Y, Saito H, Seishi Y et al. A combination of liposomal sunitinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse. J. Drug Target. 20(10), 873–882 (2012).Crossref, Medline, CAS, Google Scholar13 Zhang YF, Wang JC, Bian DY et al. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies. Eur. J. Pharm. Biopharm. 74(3), 467–473 (2010).Crossref, Medline, CAS, Google Scholar14 Chen Y, Zhu X, Zhang X, Liu B, Huang L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 18(9), 1650–1656 (2010).Crossref, Medline, CAS, Google Scholar15 Shim G, Han SE, Yu YH et al. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug. J. Controlled Release 155(1), 60–66 (2011).Crossref, Medline, CAS, Google Scholar16 Kang SH, Cho HJ, Shim G et al. Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy. Pharm. Res. 28(12), 3069–3078 (2011).Crossref, Medline, CAS, Google Scholar17 Xiao W, Chen X, Yang L et al. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. Int. J. Pharm. 393(1–2), 119–126 (2010).Crossref, Medline, CAS, Google Scholar18 Zhang Y, Schwerbrock NMJ, Rogers AB et al. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. Mol. Ther. 21(8), 1559–1569 (2013).Crossref, Medline, CAS, Google Scholar19 Zhang M, Garbuzenko OB, Reuhl KR, Rodriguez-Rodriguez L, Minko T., Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. Nanomedicine 7(2), 185–197 (2012).Link, CAS, Google Scholar20 Sochanik A, Mitrus I, Smolarczyk R et al. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent. Arch. Immunol. Ther. Exp. (Warsz) 58(3), 235–245 (2010).Crossref, Medline, CAS, Google Scholar21 Koo YT, Falcao C, Torchilin VP. Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy. Mol. Pharm. 6(3), 971–977 (2009).Crossref, Medline, Google Scholar22 Jiang T, Mo R, Bellotti A et al. Gel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy. Adv. Funct. Mater. 24(16), 2295–2304 (2014).Crossref, CAS, Google Scholar23 Wu GH, Milkhailovsky A, Khant HA et al. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J. Am. Chem. Soc. 130(26), 8175–8177 (2008).Crossref, Medline, CAS, Google Scholar24 Mo R, Jiang T, Gu Z. Enhanced anticancer efficacy by ATP-mediated liposomal. drug delivery. Angew. Chem. Int. Ed. 53(23), 5815–5820 (2014).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByEngineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applicationsBiotechnology Advances, Vol. 67Engineered Extracellular Vesicles with Compound-Induced Cargo Delivery to Solid Tumors27 May 2023 | International Journal of Molecular Sciences, Vol. 24, No. 11ZnO Nanorods Create a Hypoxic State with Induction of HIF-1 and EPAS1, Autophagy, and Mitophagy in Cancer and Non-Cancer Cells9 April 2023 | International Journal of Molecular Sciences, Vol. 24, No. 8Amphiphilic Polypeptides Obtained by Post-Polymerization Modification of Poly-l-Lysine as Systems for Combined Delivery of Paclitaxel and siRNA21 April 2023 | Pharmaceutics, Vol. 15, No. 4Lipid Nanocarriers for Breast Cancer Treatment14 December 2022pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy6 January 2023 | Pharmaceutics, Vol. 15, No. 1Chitosan-Boric Acid Scaffolds for Doxorubicin Delivery in the Osteosarcoma Treatment6 November 2022 | Polymers, Vol. 14, No. 21Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy6 September 2022 | Frontiers in Bioengineering and Biotechnology, Vol. 10Congo Red as a Supramolecular Carrier System for Doxorubicin: An Approach to Understanding the Mechanism of Action11 August 2022 | International Journal of Molecular Sciences, Vol. 23, No. 16Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices8 June 2022 | Expert Opinion on Drug Delivery, Vol. 19, No. 6Composite Materials Based on Gelatin and Iron Oxide Nanoparticles for MRI Accuracy12 May 2022 | Materials, Vol. 15, No. 10Zinc Oxide Nanoparticles Ameliorate Dimethylnitrosamine-Induced Renal Toxicity in Rat2 December 2021 | Applied Biochemistry and Biotechnology, Vol. 194, No. 4Multifunctional carbon dot anchored halloysite nanotube: Nanovehicle for cisplatin drug release, cytotoxicity on breast cancer cells and DNA binding studiesChemical Data Collections, Vol. 38Doxorubicin Release from Bovine Serum Albumin Microparticles11 February 2022 | Pharmaceutical Chemistry Journal, Vol. 55, No. 11A review of Nigella sativa and its active principles as anticancer agentsPlant Pollen Grains: A Move Towards Green Drug and Vaccine Delivery Systems15 May 2021 | Nano-Micro Letters, Vol. 13, No. 1Autonomously Propelled Colloids for Penetration and Payload Delivery in Complex Extracellular Matrices6 October 2021 | Micromachines, Vol. 12, No. 10Polymer incorporated magnetic nanoparticles: Applications for magnetoresponsive targeted drug deliveryMaterials Science and Engineering: B, Vol. 272A DFT Study of Graphitic Carbon Nitride as Drug Delivery Carrier for Flutamide (Anticancer Drug)21 June 2021 | Journal of Computational Biophysics and Chemistry, Vol. 20, No. 04Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunitiesInternational Journal of Biological Macromolecules, Vol. 178Delivery of eupenifeldin via polymer-coated surgical buttresses prevents local lung cancer recurrenceJournal of Controlled Release, Vol. 331Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics26 January 2021 | Biomedicines, Vol. 9, No. 2Material and strategies used in oncology drug deliveryAlginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting13 March 2020 | Journal of Biological Engineering, Vol. 14, No. 1In-vitro and in-vivo evaluation of polymeric microsphere formulation for colon targeted delivery of 5-fluorouracil using biocompatible natural gum katiraInternational Journal of Biological Macromolecules, Vol. 158Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇAsian Journal of Pharmaceutical Sciences, Vol. 15, No. 3pH-responsive nanomicelles of poly(ethylene glycol)-poly(ε-caprolactone)-poly(L-histidine) for targeted drug delivery11 November 2019 | Journal of Biomaterials Science, Polymer Edition, Vol. 31, No. 3Bifidobacterium spp: the promising Trojan Horse in the era of precision oncologyNealie Ngo, Khalil Choucair, Justin F Creeden, Hanan Qaqish, Krupa Bhavsar, Chantal Murphy, Kendra Lian, Mary T Albrethsen, Laura Stanbery, Richard C Phinney, F Charles Brunicardi, Lance Dworkin & John Nemunaitis31 October 2019 | Future Oncology, Vol. 15, No. 33Understanding the Nano-bio Interfaces: Lipid-Coatings for Inorganic Nanoparticles as Promising Strategy for Biomedical Applications15 May 2019 | Frontiers in Chemistry, Vol. 7Recent Advances in Chitosan-Based Systems for Delivery of Anticancer Drugs6 March 2020Combinational delivery therapies of nucleic acids for cancer treatmentDual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance11 March 2019 | Drug Delivery, Vol. 26, No. 1Controlled drug delivery vehicles for cancer treatment and their performance16 March 2018 | Signal Transduction and Targeted Therapy, Vol. 3, No. 1Recent Advances in Self-assembled Nano-therapeutics26 December 2017 | Chinese Journal of Polymer Science, Vol. 36, No. 3Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine2 October 2017 | AAPS PharmSciTech, Vol. 19, No. 2Liposome-targeted delivery for highly potent drugs17 February 2017 | Artificial Cells, Nanomedicine, and Biotechnology, Vol. 45, No. 8Liposome-Coated Persistent Luminescence Nanoparticles as Luminescence Trackable Drug Carrier for Chemotherapy15 June 2017 | Analytical Chemistry, Vol. 89, No. 13Zinc oxide nanoparticles antagonize the effect of Cetuximab on head and neck squamous cell carcinoma in vitro11 May 2017 | Cancer Biology & Therapy, Vol. 18, No. 7Nanoformulations for combination or cascade anticancer therapyAdvanced Drug Delivery Reviews, Vol. 115Liposome-based drug co-delivery systems in cancer cellsMaterials Science and Engineering: C, Vol. 71Zinc oxide nanoparticles as a novel anticancer approach; in vitro and in vivo evidence24 January 2017 | Clinical and Experimental Pharmacology and Physiology, Vol. 44, No. 2Nanoscale Drugs: A Key to Revolutionary Progress in Pharmacy and Healthcare2 December 2016Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy1 January 2017 | Biomaterials Science, Vol. 5, No. 8DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting17 October 2016 | Drug Delivery, Vol. 23, No. 9Co-delivery of drugs and plasmid DNA for cancer therapyAdvanced Drug Delivery Reviews, Vol. 98Co-delivery of chemotherapeutics and proteins for synergistic therapyAdvanced Drug Delivery Reviews, Vol. 98Recent advances of cocktail chemotherapy by combination drug delivery systemsAdvanced Drug Delivery Reviews, Vol. 98A poly(ascorbyl acrylate)-containing nanoplatform with anticancer activity and the sequential combination therapy with its loaded paclitaxel1 January 2016 | Journal of Materials Chemistry B, Vol. 4, No. 40Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatmentBiomaterials, Vol. 73Furin-Mediated Sequential Delivery of Anticancer Cytokine and Small-Molecule Drug Shuttled by Graphene15 December 2014 | Advanced Materials, Vol. 27, No. 6Development of individualized anti-metastasis strategies by engineering nanomedicines1 January 2015 | Chemical Society Reviews, Vol. 44, No. 17Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells1 January 2015 | Journal of Materials Chemistry B, Vol. 3, No. 8 Vol. 9, No. 8 STAY CONNECTED Metrics Downloaded 458 times History Published online 14 August 2014 Published in print June 2014 Information© Future Medicine LtdKeywordschemotherapyco-deliverycombination cancer therapydrug deliverygene therapyliposomeprotein therapyFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download

NIR‐Triggered Anticancer Drug Delivery by Upconverting Nanoparticles with Integrated Azobenzene‐Modified Mesoporous Silica

Obstacles Impeding the Development of Nanocarriers for Anticancer Drugs

A Tumor‐Acidity‐Activated Charge‐Conversional Nanogel As an Intelligent Vehicle for Promoted Tumoral‐Cell Uptake and Drug Delivery

RGD-modified PEG-PAMAM-DOX Conjugate: in Vitro and in Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells.

Tailoring the Ph-Induced Aggregation Behaviors of Mixed-Charge Gold Nanoparticles for Photothermal Therapy

Endosome-mimicking Nanogels for Targeted Drug Delivery

MP37-04 EFFICACY-SHAPING NANOMEDICINE BY THE LOADING OF CALCIUM PEROXIDE INTO TUMOR MICROENVIRONMENT-RESPONSIVE NANOPARTICLES FOR THE ANTITUMOR THERAPY OF PROSTATE CANCER

Correction to “Nir-Activated Polymeric Nanoplatform with Upper Critical Solution Temperature for Image-Guided Synergistic Photothermal Therapy and Chemotherapy”

Functional Mesoporous Silica Nanoparticles for Photothermal‐Controlled Drug Delivery in Vivo

Nanomedicine in Boron Neutron Capture Therapy for Cancer Treatment: Opportunities, Challenges and Future Perspectives

Controlled Self‐Assembling of Gadolinium Nanoparticles As Smart Molecular Magnetic Resonance Imaging Contrast Agents

Tumor Receptor-Mediated In Vivo Modulation of the Morphology, Phototherapeutic Properties, and Pharmacokinetics of Smart Nanomaterials

Multifunctional Nanoparticles Displaying Magnetization and Near‐IR Absorption

Correction to "Diketopyrrolopyrrole-Triphenylamine Organic Nanoparticles As Multifunctional Reagents for Photoacoustic Imaging-Guided Photodynamic/Photothermal Synergistic Tumor Therapy".

Drug Delivery: Furin-Mediated Sequential Delivery of Anticancer Cytokine and Small-Molecule Drug Shuttled by Graphene (adv. Mater. 6/2015)

A Near-Infrared Laser-Triggered Size-Shrinkable Nanosystem with In Situ Drug Release for Deep Tumor Penetration

Recent Progress in Multidrug Delivery to Cancer Cells by Liposomes

A Controlled‐Release Nanocarrier with Extracellular Ph Value Driven Tumor Targeting and Translocation for Drug Delivery

Photodynamic Therapy: Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity (small 13/2017)

Near-Infrared Light-Triggered Intracellular Delivery of Anticancer Drugs Using Porous Silicon Nanoparticles Conjugated with IR820 Dyes

A NIR-laser smart stimulus self-assembly nanosystem with acid-activatable for enhanced photothermal and chemotherapy against tumors